The vast majority of biotechnology and synthetic biology capabilities remain limited to the 20! laboratory due to issues with reagent stability, robustness, and safety concerns. This is 21! particularly true of protein-based applications, which often capitalize on the inherent properties 22! ! 2! of natural products, but remain challenging from a storage perspective. Recently, cell-free 23! protein expression systems have been suggested as a promising path for protein-based 24! applications, as they simplify protein expression, purification, and screening while offering 25! safety advantages over engineered living cells [1][2][3][4][5][6][7][8] . However, cell-free reaction components still 26! suffer from preservation concerns, typically requiring cold-chain storage. The ability to preserve 27! and store protein production machinery, particularly at and above room temperature, would drive 28! a breadth of new applications, enabling therapeutics, biosensors, and remediation approaches 9, 10 , 29! including in emergency situations or remote field locations where delivery of lab synthesized 30! products is infeasible. 31!
INTRODUCTION

18! 19!
The vast majority of biotechnology and synthetic biology capabilities remain limited to the 20! laboratory due to issues with reagent stability, robustness, and safety concerns. This is 21! particularly true of protein-based applications, which often capitalize on the inherent properties 22! ! 2! of natural products, but remain challenging from a storage perspective. Recently, cell-free 23! protein expression systems have been suggested as a promising path for protein-based 24! applications, as they simplify protein expression, purification, and screening while offering 25! safety advantages over engineered living cells [1] [2] [3] [4] [5] [6] [7] [8] . However, cell-free reaction components still 26! suffer from preservation concerns, typically requiring cold-chain storage. The ability to preserve 27! and store protein production machinery, particularly at and above room temperature, would drive 28! a breadth of new applications, enabling therapeutics, biosensors, and remediation approaches 9, 10 , 29! including in emergency situations or remote field locations where delivery of lab synthesized 30! products is infeasible. 31!
32!
To pave a path towards these applications, we sought to develop an approach that meets all of the 33! following criteria: 1) preservation of all components needed for transcription and translation, 2) 34! long-term heat stability, 3) potential for scalability, 4) stability under atmospheric conditions, 35! and 5) ability to produce an active therapeutic using stored reagents. The preservation of protein 36! expression systems is challenging because these systems consist of around one hundred essential 37! proteins and small molecules.
11 Previously, several important efforts have taken steps towards 38! realizing some, but not all of the above criteria. In particular, there is a lack of methods to date 39! that demonstrate long term heat stability.
40! 41!
Two early cell-free preservation efforts focused on drying wheat germ translation systems with 42! stabilizers. These studies, however, did not demonstrate long-term heat stabilization (e.g.
43!
months at 37°C). 12, 13 More recently, Pardee et al. took a major step towards fieldable protein 44! expression systems when they lyophilized cell-free reagents and used them to both implement 45! ! 3! biosensor gene networks capable of detecting Ebola 14 and Zika virus 15 and also to produce a 46! wide array of therapeutics 16 . Although the Pardee et al. methods demonstrate stabilization at 47! room temperature, they still do not fully address the ruggedness needs for many applications.
48!
First, long-term (one year) stability for their pellet-based approach was demonstrated using an 49! inert gas atmosphere (N 2 ) to prevent oxidative damage, and a silicon desiccant package to 50! prevent hydrolytic damage 14 . Second, their paper-based approach for short-term (24 h) storage is 51! excellent for many small-scale biosensing applications, but not for larger scale applications (e.g., 52! remediation or therapeutics) requiring high volumes of extract. !Finally, significant heat 53! resilience above room temperature was not demonstrated 13, 17 . Another important work by Smith 54! et al similarly presented the testing of preserved cell extract stored for different durations at room 55! temperature. In this study, however, either fresh energy system reagents (e.g.
56!
phosphoenolpyruvate, ammonium glutamate, potassium glutamate, potassium oxalate, NAD, 57! CoA, nucleotide triphosphates, folinic acid, and tRNA) were added at each timepoint, or the 58! stability of dried energy system reagents at room temperature was characterized using fresh 59! extract 17 . Given that both the extract and energy system exhibit pronounced declines in efficacy 60! over two months, it is unclear how a full set of preserved essential cell-free system components 61! would perform. In addition, in this approach, amino acids, spermidine, and putrescine were 62! added separately, and the stability of these reagents was not presented. Finally, reconstitution of 63! the energy system in this design necessitated the addition of optimal amounts of sodium 64! hydroxide, requiring testing with litmus paper. An interesting extension of the Smith et al.
65!
approach was recently presented as well. Lyophilized extract was tested at 25°C over the course 66! of a year. Again, however, the addition of fresh energy system reagents appeared to be 67! required.
18 Moreover, dried, but not shelf-stored extract was used to produce a 12 kDa 68! (Fig. 1a ). We then demonstrate the application potential of 77! our approach by using preserved, heat-stressed reagents to produce sufficient concentrations of a 78! pyocin protein to kill the opportunistic human pathogen Pseudomonas aeruginosa. 79!
80!
RESULTS
81!
82!
We first produced cell-free reagents and defined an assay for quantifying expression capacity. 83! Specifically, we produced E. coli extracts using sonication 19 and leveraged a simplified cell-free 84! reagent production protocol (see Methods) 20 . To quantify expression, we measured fluorescence 85! resulting from expression of enhanced green fluorescent protein (EGFP) from the pUC-T7tet-86! T7term plasmid. Although we normalize all subsequent fluorescence measurements to a 87! standard experiment with fresh reagents (see Methods), we first compared the efficacy of our 88! reagents to a commercial kit in order to provide a frame of reference ( Supplementary Fig. 1 ).
89!
This analysis showed that our reagents outperformed a comparable commercial system by 60%. Having produced reagents and defined an expression assay, we then characterized the baseline 92! stability of our cell-free reaction mixture through daily monitoring of the mixtures' ability to 93! express enhanced green fluorescent protein (EGFP) from the pUC-T7tet-T7term plasmid. After 94! only a single day at either room temperature or 37°C, unpreserved reaction mixture failed to 95! generate fluorescence (Fig. 1b) . Next, we used the same approach to separately characterize the 96! stability of the two main components of the reaction mixture, namely the cell extract and the 97! reaction buffer. For this, days old cell extract was combined with fresh reaction buffer, while 98! days old reaction buffer was combined with fresh cell extract. The EGFP expression plasmid was 99! then added to each sample and the samples were assayed. After 4 d at room temperature, cell 100! extract efficacy had decreased by 31.1-fold. After only 1 d under 37°C heat stress, the extract 101! had completely lost viability and generated negligible fluorescence in our expression assay ( Fig.  102!   1c ). By contrast, at room temperature, buffer efficacy remained high for 43 d and then rapidly 103! decreased (Fig. 1d) . However, after only 9 d at 37°C, buffer efficacy was reduced by 41.5-fold. 104!
105!
Next, we tested the stability of open-air dried reagents. For this, we stored magnesium acetate (a 106! known deliquescent) separately and only combined it with other reagents at the time of assay. 107! Magnesium acetate was separated to enhance stability of dried reagents to hydrolytic damage 21 .
108!
Stability quantification experiments were conducted similarly to the initial baseline 109! characterizations. Specifically, (i) dried reaction mixture was reconstituted with water to the 110! appropriate volume, (ii) dried cell extract was reconstituted and combined with fresh reaction 111! buffer and (iii) dried reaction buffer was reconstituted and combined with fresh cell extract.
112!
Finally, the EGFP expression plasmid and magnesium acetate were added to each sample and the 113! samples were assayed. Interestingly, while dried reaction mixture completely lost viability after 114! 1 d (Fig. 2a) , individually stored extract and reaction buffer still exhibited significant protein 115! expression capacity even after 3 d (Fig. 2b-c ). This suggested a potential benefit to separately 116! preserving extract and reaction buffer. Also, although extract was less stable than reaction buffer 117! in liquid form (Fig. 1c-d) , dried extract was more stable than dried reaction buffer (Fig. 2b-c) .
118!
Specifically, even after 40 d, dried extract exhibited less than a 10-fold decrease in expression 119! yield, whereas dried reaction buffer completely lost viability after 6 d. 120!
121!
While simply drying cell extract improved stability, the significant decreases in the efficacy of 122! extract and reaction buffer over a month suggested the need for identifying preserving agents.
123!
For this, we selected the non-reducing sugar alcohol, trehalose. We chose trehalose because it is 124! implicated in anhydrobiosis in natural organisms such as the tardigrade (water bear or moss 125! piglet) 22 , has been widely used in preservation applications 23 , and can be produced in a cost 126! effective manner 24 . As expected, trehalose dramatically extended the shelf life of preserved cell-127! free systems. Whereas reaction mixture dried without trehalose lacked viability after 1 d, 128! reaction mixture dried with trehalose did not undergo a full 10-fold reduction in yield until after 129! 40 d at 37°C (Fig. 2a) . Cell extract efficacy was similarly stabilized over longer time periods 130! (over three months) when dried with trehalose ( Fig. 2b) , as was dried reaction buffer which, with 131! the addition of trehalose, maintained full stability for 20 d before gradually declining (Fig. 2c) . (Fig. 2d vs. Fig 2c) .
141! 142!
Having demonstrated successful expression from preserved cell extract and fresh reaction buffer 143! and from preserved reaction buffer and fresh cell extract, we next tested system performance 144! when preserved cell extract is mixed with preserved reaction buffer. Figure 2e shows expression 145! yield vs. storage time at 37°C for cases in which all expression components (extract, reaction 146! buffer, creatine phosphate, and magnesium acetate) are preserved, heat stressed, and 147! reconstituted (see also Supplementary Fig. 5 ). In all cases, expression yield is initially lower 148! when preserved extract is used (Fig. 2e ) as opposed to fresh extract (Fig. 2d) . This is at least 149! partially due to the fact that, when both extract and reaction buffer components are preserved, 150! reconstituted, and combined, the final concentration of trehalose is higher -a consequence of 151! including trehalose in both the extract and the buffer preservation procedures. High 152! concentrations of trehalose can lower protein expression rates ( Supplementary Fig. 6 ).
153!
Nonetheless, significant expression is realized for over three months of storage. In a similar 154! experiment for a longer time period, we found that, although expression begins to decrease after Having established a cell-free reagent preservation approach, we sought to demonstrate 173! therapeutic application potential. For this, we used our preserved protein expression system to 174! produce pyocin S5, a 56.1 kDa protein, which, upon proper folding, forms lethal pores in 175! susceptible strains of the pathogen P. aeruginosa 25, 26 . To test the long-term therapeutic efficacy 176! of our system, we used both plate clearing and broth dilution assays. The plate clearing 177! experiments in Figure 3a ,c show that complete clearing was achieved at all time points 178! throughout the 136 d of heat stress. Likewise, the broth dilution experiments (Figure 3b,d) show 179! that the survival fraction of P. aeruginosa was reduced by 4 logs or more (depending on 180! trehalose concentration) using a 20-fold dilution of pyocin produced from 136-day-old, heat-181! stressed (37°C) cell-free reagents (extract, reaction buffer, magnesium acetate, and creatine 182! phosphate). Impressively, throughout the 136 d experiment a 100-fold dilution of pyocin 183! ! 9! produced from reconstituted cell-free reagents was sufficient to achieve a 100-fold reduction in 184! the P. aeruginosa survival fraction. To further quantify these results, we calculated MIC values 185! and found that they ranged within an order of magnitude for the duration of the 136-day 186! experiment (Supplemental Note 2, Supplementary Figure 8) . 
Plasmids
271!
The EGFP expression construct pUCT7tet-T7term expresses EGFP from a TetR repressible T7 272! promoter variant and has been previously described 7 . The pyocin expression construct pT7-273! pyoS5, expresses pyocin S5 from P. aeruginosa PAO-1 from a T7 promoter. More specifically, 274! it contains a T7 promoter, a strong ribosome binding site, the pyoS5 gene, and a T7 terminator in 275! a modified pUC19 backbone. This plasmid was constructed using DNA synthesized by GeneArt 276! and assembled through Seamless Cloning reactions. To establish an initial preservation performance baseline, we conducted experiments to 305! determine the inherent shelf life of cell-free reaction mixture (Fig. 1) . To characterize reaction 306! mixture stability, we first sterilized reaction mixture through 0.22 µm filtration to prevent initial 307! fouling that may obscure inherent biochemical stability. Aliquots of filtered reaction mixture 308! were then stored at room temperature and at 37°C. At different time points, the plasmid pUC-309! T7tet-T7term was added to express enhanced green fluorescent protein (EGFP) from a T7 310! promoter variant. Using a microplate reader, the fluorescence intensity after 5 h of incubation 311! was measured to quantify expression, as described in the GFP expression assay section above. 312!
313!
To gain a deeper understanding of reaction mixture degradation, we also characterized cell 314! extract and reaction buffer stability separately. To quantify cell extract stability, we stored 315! aliquots at room temperature and at 37°C. At different time points, we added fresh reaction 316! ! 15! buffer and the pUC-T7tet-T7term expression construct and assayed fluorescence as was done to 317! test the full reaction mixture (Fig. 1c) . After 4 d at room temperature, cell extract efficacy had 318! decreased by a factor of 31.1. After only one day under heat stress, the extract completely lost 319! viability and generated negligible fluorescence in our expression assay. To test reaction buffer 320! stability, we similarly added fresh extract and the expression construct and quantified 321! fluorescence at different time points (Fig. 1d) . At room temperature, buffer efficacy remained 322! high for 43 d and then rapidly decreased. However, after only 9 d at 37°C, the buffer efficacy 323! was reduced by a 41.5-fold. 324!
325!
Preservation and reconstitution
326!
We utilized a simple open-air drying approach. This approach was chosen due to its simplicity 327! and low cost. Also, the fact that the final product is not trapped in a porous material such as 328! paper facilitates transport and large-scale applications. All of the following approaches could be 329! adapted to other drying methods, such as freeze-drying or spray-drying, if desired. Prior to 330! drying, all reagents were filtered using 0.22 µm spin filters (Millipore). All drying was 331! performed by pipetting small aliquots (14-28 µL) on a silicon sheet (Silpat). The sheet was then 332! placed in a 37°C incubator. Dried samples were recovered using a razor and transferred to 333! DNAse/RNAse free 1.5 mL microcentrifuge tubes. Temperature and humidity were quantified 334! using an Inkbird THC-4 digital sensor. For instance, for the experiments in Figure 3 , the average 335! temperature was 37.1°C (σ=0.8°C), and the average relative humidity was 20.5% (σ=4.3%). components to perform protein expression reactions. Pyocin S5 was expressed using the T7 359! expression plasmid pT7-pyoS5, and EGFP was expressed using pUCT7tet-T7term. These 360! reactions were incubated in microcentrifuge tubes in a rotator at 30°C. After 6 h, different 361! dilutions of the pyocin reaction were prepared, whereby the EGFP reaction product was used to 362! dilute the pyocin reaction product. 363!
364!
For each time point in Figure 3 , 14 samples were set up for analysis by plate clearing and broth 365! dilution assays. Of these 14 samples, 13 consisted of two-fold serial dilutions of the pyocin cell-366! free reaction product, using the cell-free EGFP reaction product to dilute the pyocin product.
367!
The final sample consisted of the cell-free EGFP reaction product, which served as a negative 368! 
